Review
Infectious Diseases
Abdollah Ardebili, Ahdieh Izanloo, Mostafa Rastegar
Summary: The increasing prevalence of infections with multidrug-resistant (MDR), extensively-drug resistant (XDR) or difficult-to-treat (DTR) Gram-negative bacilli poses a severe challenge. Polymyxins, such as polymyxin B and colistin, have become a mainstay in clinical practices for treating these infections. However, the effect of polymyxin combination therapy versus monotherapy on treating Gram-negative bacilli-related infections is still unclear.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
(2023)
Article
Immunology
You Li, Siwei Guo, Xin Li, Yunsong Yu, Bingqian Yan, Miaomei Tian, Bing Xu, Huangdu Hu
Summary: This study evaluated the in vitro synergy of polymyxin B (PMB) combined with other antibiotics against PMB-resistant gram-negative bacilli (GNBs). The results showed that PMB combined with tigecycline and avibactam-based beta-lactam beta-lactamase inhibitors (BL-BLIs) could be a potential clinical option for the treatment of infections caused by PMB-resistant GNBs.
MICROBIAL PATHOGENESIS
(2022)
Article
Medicine, Research & Experimental
Xiaojuan Zhang, Shaoyan Qi, Xiaoguang Duan, Bing Han, Shuguang Zhang, Shaohua Liu, Haixu Wang, Haibo Zhang, Tongwen Sun
Summary: This study evaluated the effectiveness and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacilli infections. The results showed positive clinical outcomes, with a relatively high bacteria eradication rate but also significant mortality at 28 days. Adverse reactions, including nephrotoxicity, were observed in a portion of patients.
JOURNAL OF TRANSLATIONAL MEDICINE
(2021)
Article
Microbiology
Shuang Xiao, Qianwen Fu, Youhan Miao, Manna Zhao, Shengwei Lu, Jie Xu, Weifeng Zhao
Summary: This study retrospectively analyzed the data of 139 patients treated with Ceftazidime-Avibactam (CAZ-AVI) for Carbapenem-resistant Gram-negative bacilli (CR-GNB) infections. The results showed that CAZ-AVI had high clinical efficacy and bacterial clearance. Compared to Polymyxin B, CAZ-AVI had better outcomes and lower adverse events. However, there was a 14.6% resistance rate to CAZ-AVI, with Carbapenem-resistant Klebsiella pneumoniae (CRKP) and Carbapenem-resistant Pseudomonas aeruginosa (CRPA) showing resistance rates of 13.5% and 15.4%, respectively.
FRONTIERS IN MICROBIOLOGY
(2023)
Article
Public, Environmental & Occupational Health
Heba Alhmidi, Jennifer L. Cadnum, Sreelatha Koganti, Annette L. Jencson, Brigid M. Wilson, Curtis J. Donskey
Summary: Limited information is available on the frequency of and risk factors for shedding of health care-associated pathogens in settings outside patient rooms. The study found that environmental shedding of MRSA occurs frequently during appointments outside hospital rooms or during outpatient clinic visits, and the presence of a wound with a positive culture for MRSA was associated with shedding of MRSA during appointments.
AMERICAN JOURNAL OF INFECTION CONTROL
(2021)
Article
Microbiology
Patricia Orlandi Barth, Fabiana Caroline Zempulski Volpato, Natalia Kehl Moreira, Priscila Lamb Wink, Andrea Celestino de Souza, Afonso Luis Barth
Summary: Infections caused by multidrug-resistant microorganisms, especially Gram-negative bacilli, have become a global concern in hospital environments. The production of carbapenemase enzymes in these bacteria makes them resistant to most beta-lactam antibiotics, including carbapenems. Polymyxins have been reintroduced as a last resort to treat carbapenem-resistant Gram-negative bacilli infections. However, evaluating the susceptibility to polymyxins currently requires a laborious and time-consuming technique.
FRONTIERS IN MICROBIOLOGY
(2022)
Article
Microbiology
Rafael Ayerbe-Algaba, Nuria Bayo, Ester Verdu, Raquel Parra-Millan, Jesus Seco, Meritxell Teixido, Jeronimo Pachon, Ernest Giralt, Younes Smani
Summary: In this study, ten AOA-2 derivatives were synthesized and evaluated for their effects against Gram-negative bacilli infections. Among them, RW01 and RW06 showed promising potential in improving the inhibitory effect of AOA-2, specifically against Pseudomonas aeruginosa and Escherichia coli by reducing bacterial adherence to host cells while slightly improving the viability of infected cells. Additionally, RW01 and RW06 also potentiated the activity of colistin against Acinetobacter baumannii strain, highlighting their potential as effective antimicrobial agents.
FRONTIERS IN MICROBIOLOGY
(2021)
Article
Microbiology
Maytham Hussein, Raad Jasim, Hakan Gocol, Mark Baker, Varsha J. J. Thombare, James Ziogas, Aayush Purohit, Gauri G. G. Rao, Jian Li, Tony Velkov
Summary: Outer membrane vesicles (OMVs) can help bacteria to fight antibiotics by spreading resistance genes and acting as protective armor. Proteomic analysis revealed that OMVs shield K. pneumoniae and act as decoys against polymyxin attack by reducing the export of resistance-related proteins. Comparative proteomics of OMVs from polymyxin-susceptible and resistant strains identified perturbed pathways and highlighted the potential roles of OMVs in adhesion, virulence, and antibiotic resistance. These findings provide new insights into the importance of OMVs in the bacterial response to polymyxins.
Article
Chemistry, Multidisciplinary
Rundong Zhu, Zenglin Yin, Nan Liu, Zengming Wang, Hui Zhang, Jianchun Li, Liao Shen, Aiping Zheng
Summary: This study developed bacteria-targeted liposomes for enhanced antibiotic delivery and demonstrated that the adsorption of polymyxin B onto the liposome surface achieved effective bacterial targeting. Compared to free antibiotics, these liposomes showed improved therapeutic efficacy against bacterial infections and reduced adverse drug reactions.
Article
Biophysics
Yuliang Sun, Zhixiong Deng, Xukai Jiang, Bing Yuan, Kai Yang
Summary: The study revealed that PMB has a preference for specific lipid species in its interaction with different membrane systems, leading to complex membrane interaction states. These findings provide insights into the action mechanism of PMB at a membrane level, laying the foundation for developing novel and safer polymyxin strategies for better clinical use.
COLLOIDS AND SURFACES B-BIOINTERFACES
(2022)
Article
Pharmacology & Pharmacy
Zhenping Wu, Siying Zhang, Yelin Cao, Qiyu Wang, Keyuan Sun, Xia Zheng
Summary: This study compared the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combination therapy with intravenous and nebulized polymyxin for the treatment of CR-GNB VAP. Among patients treated with nebulized polymyxin monotherapy, the clinical efficacy and toxicity of polymyxin B and polymyxin E were also compared. The results showed that nebulized polymyxin monotherapy was as effective as combination therapy and there were no differences in clinical efficacy and toxicity between polymyxin B and polymyxin E during nebulized polymyxin therapy.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Critical Care Medicine
Jiao Liu, Min Shao, Qianghong Xu, Fen Liu, Xiaojun Pan, Jianfeng Wu, Lihong Xiong, Yueming Wu, Mi Tian, Jianying Yao, Sisi Huang, Lidi Zhang, Yizhu Chen, Sheng Zhang, Zhenliang Wen, Hangxiang Du, Tao Wang, Yongan Liu, Wenzhe Li, Yan Xu, Jean-louis Teboul, Dechang Chen
Summary: The addition of inhaled plus intravenous polymyxin B therapy showed improved favorable clinical outcomes in patients with extensively drug-resistant Gram-negative bacilli-induced ventilator-associated pneumonia, but it did not provide efficient clinical cure and bacterial eradication.
ANNALS OF INTENSIVE CARE
(2022)
Article
Chemistry, Medicinal
Emma van Groesen, Cornelis J. Slingerland, Paolo Innocenti, Milos Mihajlovic, Rosalinde Masereeuw, Nathaniel Martin
Summary: Vancomycin binds to lipid II to exert its antimicrobial effect, but cannot pass through the outer membrane of Gram-negative bacteria. Conjugation of vancomycin with OM disrupting PMEN results in hybrid vancomyxins with improved activity against Gram-negative strains and maintained antimicrobial effect against Gram-positive strains. The hybrid antibiotics show reduced nephrotoxicity compared to clinically used polymyxin antibiotics.
ACS INFECTIOUS DISEASES
(2021)
Article
Immunology
Shi Wu, Dandan Yin, Peiyuan Zhi, Yan Guo, Yang Yang, Demei Zhu, Fupin Hu
Summary: This study evaluated the in vitro antibacterial activity of MRX-8 against gram-negative bacteria recently isolated from China. The results showed that MRX-8 was effective against most clinically isolated gram-negative isolates, especially carbapenem-resistant bacteria.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2022)
Article
Pharmacology & Pharmacy
Xuedong Jia, Zhao Yin, Wan Zhang, Conghui Guo, Shuzhang Du, Xiaojian Zhang
Summary: This study retrospectively analyzed the use of polymyxin B in Chinese children and found that it can be an effective treatment for CR-GNB infection. However, monitoring of kidney function should be strengthened during treatment.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Medicine, Research & Experimental
Noorjahan Aibani, Parth Patel, Rachelle Buchanan, Stacy Strom, Kishor M. Wasan, Robert E. W. Hancock, Volker Gerdts, Ellen K. Wasan
Summary: Continuous outbreaks of pertussis highlight the need for improved immunogenicity and long-term adaptive immunity against the disease. In this study, a new acellular pertussis vaccine was developed using a triple-adjuvant system and cationic lipid nanoparticles as carriers. The vaccine showed promising results in stimulating systemic and mucosal immune responses, particularly with higher levels of Th1-type antibodies and early nasal antibody response.
MOLECULAR PHARMACEUTICS
(2022)
Article
Multidisciplinary Sciences
Morgan A. Alford, Simranpreet Mann, Noushin Akhoundsadegh, Robert E. W. Hancock
Summary: This study demonstrated the influence of the two-component regulatory system NtrBC on the competitive advantage of Pseudomonas aeruginosa over Staphylococcus aureus in skin organoid and mouse models. Additionally, it was found that the phenotype and secretory profile of P. aeruginosa play a crucial role in maintaining this competitive edge.
SCIENTIFIC REPORTS
(2022)
Article
Biotechnology & Applied Microbiology
Chelsea Woods, Lindsey Woolley, Gavin Partridge, Mengqi Chen, Evan F. Haney, Robert E. W. Hancock, Nicky Buller, Andrew Currie
Summary: This study found that most antimicrobial peptides (AMPs) had reduced potency in high salt concentrations and were ineffective at reducing bacterial load in a typical commercial rotifer culture. Only two AMPs showed effectiveness against specific bacterial strains.
PROBIOTICS AND ANTIMICROBIAL PROTEINS
(2022)
Article
Nanoscience & Nanotechnology
Colin Blackadar, Ka-Yee Grace Choi, Mary F. Embree, Heather M. Hennkens, Cristina Rodriguez-Rodriguez, Robert E. W. Hancock, Katayoun Saatchi, Urs O. Hafeli
Summary: Single-photon emission computed tomography (SPECT) is a useful tool for noninvasively visualizing the biodistribution of silver-containing compounds in rodents. The study found that antimicrobial silver nanoparticles, formed by neutron irradiation of palladium foil, can be stably incorporated into the lungs of mice without significant uptake in other organs. In a mouse model of pulmonary Pseudomonas aeruginosa infection, the nanoparticles effectively reduced bacterial burden without inducing excessive inflammation.
ACS APPLIED MATERIALS & INTERFACES
(2022)
Article
Ecology
Christina L. Wiesmann, Yue Zhang, Morgan Alford, Corri D. Hamilton, Manisha Dosanjh, David Thoms, Melanie Dostert, Andrew Wilson, Daniel Pletzer, Robert E. W. Hancock, Cara H. Haney
Summary: Members of the bacterial genus Pseudomonas can form mutualistic, commensal, and pathogenic associations with diverse hosts. The study found that the regulatory gene ColR/S is functionally conserved between Pseudomonas aeruginosa and Pseudomonas fluorescens, but there are differences in the regulon. ColR/S allows Pseudomonas to sense and respond to a host, and the divergence of the ColR regulon may be related to different lifestyles.
Article
Multidisciplinary Sciences
Arjun Baghela, Andy An, Peter Zhang, Erica Acton, Jeff Gauthier, Elsa Brunet-Ratnasingham, Travis Blimkie, Gabriela Cohen Freue, Daniel Kaufmann, Amy H. Y. Lee, Roger C. Levesque, Robert E. W. Hancock
Summary: Severely-afflicted COVID-19 patients can exhibit sepsis-like disease manifestations, and the diagnostic tools used in managing sepsis may also be applicable to COVID-19 patients. This study analyzed the blood transcriptome of COVID-19 patients and identified gene expression signatures that are associated with severity and potential therapeutic opportunities. The expression of sepsis gene expression signatures in severely-afflicted COVID-19 patients indicates the importance of considering severe sepsis classification and using these signatures for mechanistic characterization, diagnosis, and guidance of treatment using repurposed drugs.
SCIENTIFIC REPORTS
(2023)
Article
Rheumatology
Kristen I. Gibson, Britt Drogemoller, Dirk M. Foell, Susanne Benseler, Jinko Graham, Robert E. W. A. Hancock, Raashid A. Luqmani, David L. Cabral, Kelly J. Brown, Colin Ross
Summary: This study conducted a genome-wide association study of pediatric ANCA-associated vasculitis (AAV) and found a significant genetic association between HLA-DPB1*04:01 allele and pediatric AAV. The study also suggested that childhood- and adult-onset vasculitis may share a common genetic predisposition. These findings contribute to improved classification tools and treatment strategies for AAV.
ARTHRITIS & RHEUMATOLOGY
(2023)
Article
Multidisciplinary Sciences
Shahid Chaudhary, Zahir Ali, Muhammad Tehseen, Evan F. Haney, Aaron Pantoja-Angles, Salwa Alshehri, Tiannyu Wang, Gerard J. Clancy, Maya Ayach, Charlotte Hauser, Pei-Ying Hong, Samir M. Hamdan, Robert E. W. Hancock, Magdy Mahfouz
Summary: This study demonstrates the efficient production of bioactive amidated AMPs through transient expression in Nicotiana benthamiana line expressing the mammalian enzyme peptidylglycine alpha-amidating mono-oxygenase. The AMPs purified from plants exhibit robust killing activity against highly virulent and antibiotic-resistant pathogens, and can prevent their biofilm formation when used in combination with antibiotics. The techno-economic analysis also shows the potential economic advantages and scalability for industrial use of this platform.
NATURE COMMUNICATIONS
(2023)
Article
Immunology
Arjun S. Baghela, Jasmine Tam, Travis M. Blimkie, Bhavjinder K. Dhillon, Robert E. W. Hancock
Summary: In this study, a compendium of 103 gene sets related to sepsis was built by collecting data from transcriptomic studies. The gene sets comprise 20,899 unique genes, and the study describes the commonly involved molecular mechanisms. A database called SeptiSearch was created to provide bioinformatic tools for the sepsis community to explore and validate these gene sets.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Immunology
Andy Y. An, Arjun Baghela, Peter Zhang, Reza Falsafi, Amy H. Lee, Uriel Trahtemberg, Andrew J. Baker, Claudia C. dos Santos, Robert E. W. Hancock
Summary: This study compared the gene expression trajectories between severe COVID-19 patients and contemporaneous non-COVID-19 severe sepsis patients during hospitalization. COVID-19 patients had 1,215 differentially expressed genes compared to non-COVID-19 sepsis patients at ICU admission, but the number dropped to 9 genes after one week. The findings highlight the importance of early antiviral treatment for COVID-19 and the potential for heme-related therapeutics.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Pharmacology & Pharmacy
Hashem Etayash, Fione Yip, Robert E. W. Hancock
Summary: In this study, the impacts of pegylation and glycosylation on the biocompatibility and biological properties of host defense peptides (HDPs) were investigated. It was found that both modifications significantly reduced aggregation, hemolysis, and cytotoxicity, and enhanced immunomodulatory and anti-inflammatory effects of the peptides. However, antimicrobial and antibiofilm activity was partially reduced.
Review
Pharmacology & Pharmacy
Cesar de la Fuente-Nunez, Angela Cesaro, Robert E. W. Hancock
Summary: Despite advances in antibiotic discovery, millions of people still die from infections every year. Antibiotic failure is not solely due to antibiotic resistance, but also related to biofilm formation, sepsis, and the microbiome. To address the crisis of antibiotic failure, it is necessary to explore treatment strategies beyond antibiotics and develop new anti-infectives or host-directed therapies.
DRUG RESISTANCE UPDATES
(2023)
Article
Dentistry, Oral Surgery & Medicine
Jinghao Hu, Jian Yu, He Liu, Zhejun Wang, Markus Haapasalo, Evan F. Haney, Robert E. W. Hancock, Shuli Deng, Ya Shen
Summary: This study evaluated the antimicrobial effects of commercially available mouthrinses and a D-enantiomeric peptide on oral multispecies biofilms. The results showed that DJK-5 demonstrated the highest percentage of dead bacteria and may be a potential candidate for future mouthrinses.
JOURNAL OF DENTISTRY
(2023)
Article
Immunology
Andy Y. An, Arjun Baghela, Peter Zhang, Reza Falsafi, Amy H. Lee, Uriel Trahtemberg, Andrew J. Baker, Claudia C. dos Santos, Robert E. W. Hancock
Summary: Transcriptional evidence showed persistent immune dysfunction in both severe COVID-19 and non-COVID-19 septic patients, associated with increased mortality. This highlights the potential for immunomodulatory therapies targeting common mechanisms of immune dysfunction in both diseases.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Dentistry, Oral Surgery & Medicine
Dan Wang, Jian Yu, He Liu, Tian Zhang, Evan F. Haney, Robert E. W. Hancock, Lin Peng, Ya Shen
Summary: This study aimed to investigate the effectiveness of DJK-5-D enantiomeric antibiofilm peptide on the corrosion resistance of titanium with different surface roughness. The results showed that DJK-5 effectively enhanced the corrosion resistance of titanium while killing S. mutans biofilms, with smooth surfaces more susceptible to peptide treatment.
JOURNAL OF DENTISTRY
(2023)